{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:57Z","timestamp":1791973437731,"version":"4.3.4"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jaad.2021.10.065","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T02:19:52Z","timestamp":1643941192000},"page":"937-954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Systemic sclerosis in adults. Part I: Clinical features and pathogenesis"],"prefix":"10.1016","volume":"87","author":[{"given":"Rebekka","family":"Jerjen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2021.10.065_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-020-04720-3","article-title":"Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data","volume":"41","author":"Ciaffi","year":"2021","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib3","first-page":"1539","article-title":"Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States","volume":"26","author":"Fan","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semarthrit.2018.11.002","article-title":"Contemporary epidemiology of systemic sclerosis: a population-based cohort study in the United Kingdom","volume":"49","author":"Garc\u00eda Rodr\u00edguez","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.berh.2018.08.005","article-title":"Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis","volume":"32","author":"Ingegnoli","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib6","first-page":"1004","article-title":"Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease","volume":"33","author":"Scalapino","year":"2006","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.10.065_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","article-title":"Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study","volume":"103","author":"Nihtyanova","year":"2010","journal-title":"Qjm"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an International meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jaad.2021.10.065_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.berh.2010.10.007","article-title":"Epidemiology of systemic sclerosis","volume":"24","author":"Nikpour","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","article-title":"Digital ulcers predict a worse disease course in patients with systemic sclerosis","volume":"75","author":"Mihai","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib18","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib19","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar4019","article-title":"Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement","volume":"14","author":"Valentini","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","article-title":"Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features","volume":"50","author":"Valentini","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2021.10.065_bib22","series-title":"Oral Presentations","first-page":"104.2","article-title":"OP0065 the very early diagnosis of systemic sclerosis (VEDOSS) project: predictors to develop definite disease from an international multicentre study","author":"Randone","year":"2019"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib23","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar3267","article-title":"Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study","volume":"13","author":"Van Praet","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib24","first-page":"208","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"Rongioletti","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib25","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40674-016-0050-y","article-title":"Autoantibodies and their role in scleroderma clinical care","volume":"2","author":"Domsic","year":"2016","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.jaad.2021.10.065_bib29","doi-asserted-by":"crossref","DOI":"10.21037\/jlpm.2018.09.13","article-title":"Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review","volume":"3","author":"Ceribelli","year":"2018","journal-title":"J Lab Precis Med"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.gene.6363734","article-title":"Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP","volume":"2","author":"Gilchrist","year":"2001","journal-title":"Genes Immun"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1073\/pnas.1906593116","article-title":"HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry","volume":"117","author":"Gourh","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.10.065_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/annrheumdis-2018-212999","article-title":"Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer","volume":"77","author":"Igusa","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jaad.2021.10.065_bib34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/eci.11.41","article-title":"Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling","volume":"7","author":"Sargent","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/art.40898","article-title":"A machine learning classifier for assigning individual patients with systemic sclerosis to intrinsic molecular subsets","volume":"71","author":"Franks","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","article-title":"Scleroderma mimics","volume":"14","author":"Nashel","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous manifestations of Scleroderma and Scleroderma-like disorders: a comprehensive review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","article-title":"An overview of environmental risk factors in systemic sclerosis","volume":"12","author":"De Martinis","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaad.2021.10.065_bib41","doi-asserted-by":"crossref","first-page":"6984282","DOI":"10.1155\/2018\/6984282","article-title":"Erratum to \u201cfrom localized scleroderma to systemic sclerosis: coexistence or possible evolution\u201d","volume":"2018","author":"Giuggioli","year":"2018","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib43","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib44","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-018-0099-0","article-title":"New insights into the genetics and epigenetics of systemic sclerosis","volume":"14","author":"Angiolilli","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib48","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/1529-0131(199810)41:10<1729::AID-ART5>3.0.CO;2-8","article-title":"Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population","volume":"41","author":"Tan","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00281-015-0499-z","article-title":"Genetics of systemic sclerosis","volume":"37","author":"Bossini-Castillo","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"10103","key":"10.1016\/j.jaad.2021.10.065_bib52","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2021.10.065_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/ard.50.Suppl_4.866","article-title":"The endothelium: its role in scleroderma","volume":"50","author":"Pearson","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"9434","key":"10.1016\/j.jaad.2021.10.065_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2021.10.065_bib57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2021.10.065_bib58","doi-asserted-by":"crossref","first-page":"154635","DOI":"10.1016\/j.cyto.2018.12.018","article-title":"Type I interferon dysregulation in systemic sclerosis","volume":"132","author":"Skaug","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib61","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib63","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms17071189","article-title":"Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study","volume":"17","author":"Crincoli","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4172\/2161-1149.1000235","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"08","author":"McFarlane","year":"2018","journal-title":"Rheumatology (Sunnyvale)"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/odi.12507","article-title":"The spectrum of orofacial manifestations in systemic sclerosis: a challenging management","volume":"23","author":"Jung","year":"2017","journal-title":"Oral Dis"},{"issue":"4 suppl 91","key":"10.1016\/j.jaad.2021.10.065_bib66","first-page":"S190","article-title":"Disease-related malnutrition in systemic sclerosis: evidences and implications","volume":"33","author":"Codullo","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.10.065_bib67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","article-title":"Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group","volume":"57","author":"Jaeger","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.jaad.2021.10.065_bib69","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/rheumatology\/keu533","article-title":"A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00296-019-04427-0","article-title":"Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic","volume":"40","author":"Bernardino","year":"2020","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"16","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2021.10.065_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mvr.2016.02.007","article-title":"Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients","volume":"105","author":"Ruaro","year":"2016","journal-title":"Microvasc Res"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20684","article-title":"Validation of potential classification criteria for systemic sclerosis","volume":"64","author":"Johnson","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jaad.2021.10.065_bib74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mvr.2018.03.004","article-title":"The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis","volume":"118","author":"Mihai","year":"2018","journal-title":"Microvasc Res"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2021.10.065_bib76","doi-asserted-by":"crossref","first-page":"iv43","DOI":"10.1093\/rheumatology\/kel310","article-title":"Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?","volume":"45","author":"Cutolo","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib75","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","article-title":"Fast track algorithm: how to differentiate a \u201cscleroderma pattern\u201d from a \u201cnon-scleroderma pattern","volume":"18","author":"Smith","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib77","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud\u2019s phenomenon\u2014an update on diagnosis, classification and management","volume":"38","author":"Pauling","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.10.065_bib78","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multinational qualitative research study exploring the patient experience of Raynaud\u2019s phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib79","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.180818","article-title":"Factors influencing Raynaud condition score diary outcomes in systemic sclerosis","volume":"46","author":"Pauling","year":"2019","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib80","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib81","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.081044","article-title":"Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (Itin\u00e9rAIR-Scl\u00e9rodermie)","volume":"36","author":"Tiev","year":"2009","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib82","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib83","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/acr.20342","article-title":"Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers","volume":"63","author":"B\u00e9rezn\u00e9","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.2008.094193","article-title":"Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis","volume":"69","author":"Mouthon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib86","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis","volume":"54","author":"Bruni","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-019-1822-1","article-title":"Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey","volume":"21","author":"Blagojevic","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","article-title":"Osteomyelitis complicating scleroderma digital ulcers","volume":"32","author":"Giuggioli","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib91","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/acr.22766","article-title":"Skin telangiectasia and the identification of a subset of systemic sclerosis patients with severe vascular disease","volume":"68","author":"Hurabielle","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/03009742.2015.1086432","article-title":"History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis","volume":"45","author":"Mahmood","year":"2016","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780270202","article-title":"Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis","volume":"27","author":"Steen","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jaad.2021.10.065_bib94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/BOR.0000000000000658","article-title":"Calcinosis in scleroderma made crystal clear","volume":"31","author":"Hsu","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/03009742.2016.1219766","article-title":"X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients","volume":"46","author":"Hsu","year":"2017","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.10.065_bib96","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib97","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15049077","article-title":"Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis","volume":"15","author":"Rech","year":"2016","journal-title":"Genet Mol Res"},{"issue":"6","key":"10.1016\/j.jaad.2021.10.065_bib98","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCGENETICS.109.870410","article-title":"Association of AHSG gene polymorphisms with Fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study","volume":"2","author":"Fisher","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/03009740510026751","article-title":"Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea","volume":"35","author":"Joung","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib100","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/rheumatology\/ket275","article-title":"Canadian Scleroderma Research Group. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients","volume":"52","author":"Razykov","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib101","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/art.25010","article-title":"Prevalence and clinical correlates of pruritus in patients with systemic sclerosis","volume":"61","author":"Razykov","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib102","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/acr.20257","article-title":"Association of pruritus with quality of life and disability in systemic sclerosis","volume":"62","author":"El-Baalbaki","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib103","first-page":"e71","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11926-018-0709-5","article-title":"An update on systemic sclerosis-associated pulmonary arterial hypertension: a review of the current literature","volume":"20","author":"Sundaram","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib105","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2021.10.065_bib106","first-page":"54","article-title":"Renal manifestations of systemic sclerosis\u2013Clinical features and outcome assessment","volume":"47","author":"Denton","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaad.2021.10.065_bib107","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.10.065_bib108","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3899\/jrheum.111417","article-title":"Longitudinal study of renal function in systemic sclerosis","volume":"39","author":"Caron","year":"2012","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib109","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2021.10.065_bib110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2397198318802763","article-title":"Systemic sclerosis and primary biliary cholangitis: an overlapping entity?","volume":"4","author":"Lepri","year":"2019","journal-title":"J Scleroderma Relat Disord"},{"issue":"suppl 3","key":"10.1016\/j.jaad.2021.10.065_bib111","first-page":"iii45","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib112","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/acr.22547","article-title":"Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide","volume":"67","author":"Avouac","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.jaad.2021.10.065_bib113","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.jaad.2021.10.065_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PLOS ONE"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib115","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.1780281110","article-title":"Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients","volume":"28","author":"Ferri","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.jaad.2021.10.065_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jaad.2021.10.065_bib117","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","article-title":"The clinical relevance of sexual dysfunction in systemic sclerosis","volume":"14","author":"Bruni","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.jaad.2021.10.065_bib118","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.24728","article-title":"Impaired sexual function in women with systemic sclerosis: a cross-sectional study","volume":"61","author":"Schouffoer","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2021.10.065_bib119","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000826","article-title":"Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features","volume":"5","author":"Hoffmann-Vold","year":"2019","journal-title":"RMD Open"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:04:44Z","timestamp":1759273484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0190962222001906"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.10.065","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis in adults. Part I: Clinical features and pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.10.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.10.066","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}